-5%
Xido is an oral medication that lowers blood sugar levels, classified as a sulfonylurea antidiabetic agent. It is used in the management of type 2 diabetes mellitus in adults when diet, exercise, and weight reduction alone are insufficient to control blood sugar levels.
Gliclazide, a second-generation sulfonylurea, has hypoglycemic effects and may offer beneficial properties for blood health. It works by stimulating the pancreas to release insulin through enhanced calcium ion transport across beta-cell membranes and by decreasing the liver’s glucose production.
